Loading...
XHKG
1666
Market cap536mUSD
Jul 10, Last price  
3.27HKD
1D
-0.30%
1Q
-16.37%
Jan 2017
-77.26%
IPO
390.50%
Name

Tong Ren Tang Technologies Co.

Chart & Performance

D1W1MN
XHKG:1666 chart
P/E
9.15
P/S
0.56
EPS
0.31
Div Yield, %
5.99%
Shrs. gr., 5y
Rev. gr., 5y
7.07%
Revenues
6.48b
-10.69%
1,034,768,0001,157,030,0001,211,455,0001,307,897,0001,578,914,0001,936,418,0002,447,132,0002,910,749,0003,341,166,0004,066,960,0004,665,295,0005,025,183,0005,059,638,0004,476,449,0004,607,369,0005,400,487,0005,991,841,0006,773,463,0007,259,644,0006,483,875,000
Net income
396m
-24.06%
143,456,000153,520,000160,528,000173,027,000198,342,000254,687,000330,171,000390,093,000462,187,000540,481,000595,654,000666,666,000677,815,000417,650,000467,553,000507,249,000582,888,000590,188,000521,795,000396,277,000
CFO
1.56b
+9,911.10%
127,391,000-42,264,000115,851,000231,293,000266,837,000255,830,000401,648,000375,451,000333,875,000303,843,000410,005,000679,807,000985,236,0001,051,775,000435,810,0001,033,415,000723,769,000554,175,00015,607,0001,562,433,000
Dividend
Jun 16, 20250.1966 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.
IPO date
Oct 31, 2000
Employees
4,030
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT